Early endovascular treatment for isolated internal carotid artery occlusion

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, open-label trial comparing early endovascular treatment (EVT) to best medical treatment in patients with acute ischemic stroke due to isolated internal carotid artery occlusion (iICAO). Eligible adults are randomized within 23 hours of last known well after CT/CTA/CTP or enhanced MRA confirms iICAO without ipsilateral intracranial branch occlusion and shows a target perfusion mismatch. The primary aim is to compare clinical outcomes and safety between arms, with investigators tracking reperfusion rates and functional recovery. The trial addresses a gap in high-level prospective evidence for EVT in this specific occlusion pattern, building on limited retrospective reports.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥18.
2. Clinical signs consistent with an acute ischemic stroke and randomization no later than 23 hours after the time last known to be well.
3. CTP, CTA or enhanced MRA within 1 hour before randomization showed that the offending vessel was isolated internal carotid artery occlusion, namely occlusion of C1-C6 segments (according to Bouthillier's segmentation) at any location. There was no ipsilateral intracranial branch occlusion (T or L shape of internal carotid artery, M1 or M2 segment of middle cerebral artery, A1 or A2 segment of anterior cerebral artery, P1 or P2 segment of posterior cerebral artery).
4. Neurological deficit with a NIHSS of \>5, or ≤5 points with disabling symptoms (complete hemianopsia, severe aphasia, neglect, any limb weakness that cannot sustain resistance to gravity, and functional loss that is considered by doctors and patients to be potentially disabling by clinical evaluation).
5. Mismatch: target Mismatch Profile on CT perfusion or MRI (ischemic core volume is \< 70 ml, mismatch ratio is ≥1.8 and mismatch volume is ≥15 ml); clinical-imaging mismatch defined as an ASPECTS score of more than 5, was present if perfusion data were not available or imaging quality was poor enough to be interpreted.
6. mRS Score before stroke ≤2.
7. Patient/Legally Authorized Representative has signed the Informed Consent form.

Exclusion Criteria:

1. The patient underwent carotid endarterectomy within 1 month.
2. Severe comorbid condition with life expectancy less than 6 months at baseline.
3. Other suspected cerebrovascular diseases (vasculitis, untreated cerebrovascular malformation, intracranial aneurysm, etc.) based on history and CTA/MRA.
4. Women who are pregnant or planning to become pregnant at the time of the study and who are known to be pregnant or breastfeeding at the time of admission.
5. Known life-threatening allergic reactions to contrast media or intravascular products.
6. Chronic internal carotid artery occlusion, defined as known carotid artery occlusion (imaging examination) ≥30 days before randomization or highly suspected chronic internal carotid artery occlusion based on medical history and CT/MRI.
7. Tandem occlusion, which was defined as internal carotid artery occlusion combined with large intracranial vessel occlusion (T or L shape of internal carotid artery, M1 or M2 segment of middle cerebral artery, A1 or A2 segment of anterior cerebral artery, P1 or P2 segment of posterior cerebral artery).
8. No known vascular access.
9. Suspected aortic dissection based on medical history, clinical evaluation or/and imaging.
10. Evidence of intracranial hemorrhage on CT/MRI.
11. Patient unable to come or unavailable for follow-up.
12. Pre-existing neurological or psychiatric disease that would confound the neurological or functional evaluations.
13. Seizures at stroke onset if they make the diagnosis of stroke doubtful and preclude obtaining an accurate baseline NIHSS assessment.
14. Patients have contraindications to the use of heparin and antiplatelet drugs.

Where it's running

• Sir Run Run Shaw Hospital
  Hangzhou, Zhejiang, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NeuroAiD test in mild to moderate ischemic stroke patients

  This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.

  Recruiting Phase 4 EVD Pharmacy and Medical Company Limited · Ho Chi Minh City · NCT07828210

• Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy

  This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.

  Recruiting at 9 sites Phase 3 115 People's Hospital · An Giang and 12 other locations · NCT07727395

• Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS

  This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.

  Recruiting Phase 3 University of Calgary · Sydney, Barangaroo and 12 other locations · NCT07687056

• IV tenecteplase given before clot removal for large-vessel ischemic stroke in the 4.5–24 hour window

  This trial tests whether a single IV dose of tenecteplase given before clot removal helps people with large-vessel ischemic stroke who arrive 4.5–24 hours after they were last well.

  Recruiting at 4 sites Phase 3 Xinqiao Hospital of Chongqing · Wuhan, Hubei and 3 other locations · NCT06987305

• Intra-arterial alteplase after successful reperfusion for anterior circulation ischemic stroke

  This trial tests whether giving intra-arterial alteplase after successful reperfusion improves 90-day functional outcomes for adults with anterior circulation large vessel occlusion stroke.

  Recruiting Phase 3 Central Hospital, Nancy, France · Nancy · NCT06768138

• Effectiveness of a new neurorehabilitation technology for stroke recovery

  This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.

  Recruiting Neurotechnika · Samara, Samara Oblast · NCT06753006

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.